NatureCell Co

NatureCell Co EBITDA per Share

The EBITDA per Share of NatureCell Co (007390.KQ) as of Oct 21, 2026 is -56.19 KRW. In the previous year, EBITDA per Share was 30.73 KRW — a change of -282.87% (lower).

EBITDA per Share

-56.19KRW

YoY

-282.87%

Last updated:

EBITDA per Share of NatureCell Co is 2025 -56.19 KRW. EBITDA per Share of NatureCell Co was 2024 30.73 KRW. It decreases by -282.87% lower compared to the previous year.

The NatureCell Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2016
-67.54 KRW
Jan 1, 2017
-20.08 KRW
Jan 1, 2018
42.72 KRW
Jan 1, 2019
25.22 KRW
Jan 1, 2022
-99.79 KRW
Jan 1, 2023
-155.35 KRW
Jan 1, 2024
30.73 KRW
Jan 1, 2025
-56.19 KRW
The NatureCell Co EBITDA per Share history
YEAREBITDA per ShareYoY
-56.19KRW-282.87%
30.73KRW-119.78%
-155.35KRW+55.69%
-99.79KRW-495.69%
25.22KRW-40.97%
42.72KRW-312.75%
-20.08KRW-70.27%
-67.54KRW+123.26%
-30.25KRW-348.23%
12.19KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NatureCell Co Stock analysis

What does NatureCell Co do? NatureCell Co Ltd generates revenue through three business segments. The Stem Cell Business segment develops stem cell therapeutics, manufactures stem cell culture media, sells stem cell culture cosmetics, and provides blood cell storage services. The Food Business segment produces and sells fruit beverages like tomato juice and peach juice, canned beverages such as sikhye, fruit concentrates, and health functional foods. The Hygiene Business segment manufactures and sells health hygiene products including masks, disinfectants, and wipes. These segments target consumers seeking medical solutions, healthy beverages, and personal care items. The Stem Cell Business segment serves customers interested in advanced medical treatments and skincare, while the Food Business segment caters to consumers looking for natural beverage and health food options. The Hygiene Business segment appeals to individuals prioritizing health and safety through products like masks and disinfectants. All segments focus on delivering quality products under NatureCell's brand name. NatureCell's product portfolio spans therapeutic, beverage, and hygiene categories, with each segment operating independently yet contributing to the company's overall revenue. The Stem Cell Business segment's offerings include culture media and cosmetics, the Food Business segment's products are fruit-based beverages and functional foods, and the Hygiene Business segment provides essential health care items. These diverse segments ensure a steady income stream across multiple consumer needs. NatureCell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NatureCell Co stock

EBITDA per Share of NatureCell Co is -56.19 KRW in 2025.

EBITDA per Share of NatureCell Co changed from 30.73 KRW to -56.19 KRW, representing a -282.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share NatureCell Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — NatureCell Co

All Key Metrics — NatureCell Co